451
Views
9
CrossRef citations to date
0
Altmetric
Neurology

Determinants of high cost in multiple sclerosis patients: a claims and chart review study

, , , , , & show all
Pages 1589-1597 | Received 19 Jan 2016, Accepted 17 May 2016, Published online: 25 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jack Burks, Thomas S Marshall & Xiaolan Ye. (2017) Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis. ClinicoEconomics and Outcomes Research 9, pages 251-260.
Read now

Articles from other publishers (8)

Marion SchaufHarini ChinthapatlaSeema DimriEdward LiDaniel M. Hartung. (2023) Economic burden of multiple sclerosis in the United States: A systematic literature review. Journal of Managed Care & Specialty Pharmacy 29:12, pages 1354-1368.
Crossref
Liang Liang, Nicole Kim, Jue Hou, Tianrun Cai, Kumar Dahal, Chen Lin, Sean Finan, Guergana Savovoa, Mattia Rosso, Mariann Polgar-Tucsanyi, Howard Weiner, Tanuja Chitnis, Tianxi Cai & Zongqi Xia. (2022) Temporal trends of multiple sclerosis disease activity: Electronic health records indicators. Multiple Sclerosis and Related Disorders 57, pages 103333.
Crossref
Michael Grabner, Cliff Molife, Liya Wang, Katherine B Winfree, Zhanglin Lin Cui, Gebra Cuyun Carter & Lisa M Hess. (2021) Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration. JMIR Cancer 7:2, pages e23161.
Crossref
Nils-Henning Ness, Dirk Schriefer, Rocco Haase, Benjamin Ettle & Tjalf Ziemssen. (2020) Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis. PharmacoEconomics 38:8, pages 883-892.
Crossref
Marcello Moccia, Andrea Tajani, Rosa Acampora, Elisabetta Signoriello, Guido Corbisiero, Adriano Vercellone, Primo Sergianni, Francesca Pennino, Roberta Lanzillo, Raffaele Palladino, Antonio Capacchione, Vincenzo Brescia Morra, Giacomo Lus & Maria Triassi. (2019) Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery. PLOS ONE 14:9, pages e0222012.
Crossref
Qinli Ma, Haechung Chung, Sonali Shambhu, Matthew Roe, Mark Cziraky, W Schuyler Jones & Kevin Haynes. (2019) Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health. Clinical Trials 16:4, pages 419-430.
Crossref
J. V. Hervás‐García, L. Ramió‐Torrentà, L. Brieva‐Ruiz, J. Batllé‐Nadal, E. Moral, Y. Blanco, A. Cano‐Orgaz, S. Presas‐Rodríguez, F. Torres, J. Capellades & C. Ramo‐Tello. (2018) Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double‐blind, non‐inferiority trial. European Journal of Neurology 26:3, pages 525-532.
Crossref
Jay Visaria, Nina Thomas, Tao Gu, Joseph Singer & Hiangkiat Tan. (2018) Understanding the Patient's Journey in the Diagnosis and Treatment of Multiple Sclerosis in Clinical Practice. Clinical Therapeutics 40:6, pages 926-939.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.